# Evaluate Real-World Use of Next Generation Infusion Pumps to Administer Remodulin

> **NCT05060315** · — · TERMINATED · sponsor: **United Therapeutics** · enrollment: 9 (actual)

## Conditions studied

- Pulmonary Arterial Hypertension

## Interventions

- **COMBINATION_PRODUCT:** Remunity Pump for Remodulin

## Key facts

- **NCT ID:** NCT05060315
- **Lead sponsor:** United Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2023-07-05
- **Primary completion:** 2024-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 9 (ACTUAL)
- **Why stopped:** Sponsor Decision
- **Last updated:** 2025-01-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05060315

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05060315, "Evaluate Real-World Use of Next Generation Infusion Pumps to Administer Remodulin". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT05060315. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*